April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of complications stemming from blood clots in patients with COVID-19. The journal also published two research letters and a case study on this topic.

April 23, 2020 — A new expert panel consensus statement published simultaneously in the journals Radiology: Imaging Cancer, Chest and the Journal of the American College of Radiology provides guidance to clinicians managing lung cancer screening programs and patients with lung nodules d

April 22, 2020 — IntraOp Medical Corporation announced the first patient enrolled in the 

April 22, 2020 — Siemens Healthineers has received clearance from the Food and Drug Administration (FDA) for its AIDAN artificial intelligence technologies on the Biograph family of positron emission tomography/computed tomography (PET/CT) systems, which includes the Biograph Horizon,

April 22, 2020 — Value in Health, the official journal of ISPOR — the professional society for health economics and outcomes research, announced today the publication of new research showing that uptake of lung cancer screening may depend on making testing fast and convenient.

April 22, 2020 — As medical practices are struggling with how to continue to serve their patients during the global COVID-19 pandemic, a new survey released today by the Sevocity division of Conceptual MindWorks, Inc. reveals tha

April 21, 2020 — Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility. Until late 2019, Dotarem was manufactured exclusively outside of the United States. 

April 21, 2020 — RADLogics announced new worldwide deployments and installations of the company’s AI-powered solution to support chest computed tomography (CT) imaging for COVID-19 (Coronavirus) patients.

April 20, 2020 — As the United States continues to face the unprecedented public health emergency from the COVID-19 pandemic, some areas of the country are seeing a decline in cases. As states and localities begin to stabilize, the Centers for Medicare and Medicaid Services (CMS) is issuing guidance on how local healthcare systems can resume providing non-COVID-19 care to patients without symptoms of COVID-19 in regions with low and stable incidence of the virus. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now